iBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal.
Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal.
Adv Exp Med Biol. 2020;1219:431-443. doi: 10.1007/978-3-030-34025-4_23.
Experimental tumor modeling has long supported the discovery of fundamental mechanisms of tumorigenesis and tumor progression, as well as provided platforms for the development of novel therapies. Still, the attrition rates observed today in clinical translation could be, in part, mitigated by more accurate recapitulation of environmental cues in research and preclinical models. The increasing understanding of the decisive role that tumor microenvironmental cues play in the outcome of drug response urges its integration in preclinical tumor models. In this chapter we review recent developments concerning in vitro and ex vivo approaches.
实验性肿瘤建模长期以来一直支持对肿瘤发生和肿瘤进展的基本机制的发现,并为新疗法的开发提供了平台。尽管如此,今天在临床转化中观察到的淘汰率,部分可以通过在研究和临床前模型中更准确地再现环境线索来减轻。越来越多的人认识到肿瘤微环境线索在药物反应结果中起着决定性作用,这促使人们将其整合到临床前肿瘤模型中。在本章中,我们回顾了最近在体外和离体方法方面的进展。